Felicia Chow, MD, MAS, is a neuro-infectious diseases clinician-researcher who works at the crossroads of neurology, infectious diseases, and global health. Dr. Chow’s research is focused on (1) epidemiology of infection-related stroke, (2) sex and race disparities in cerebrovascular risk in HIV infection, and (3) treatment strategies for neurotuberculosis. She is leading two international TB meningitis treatment trials sponsored by NIH/AIDS Clinical Trials Group and NIH/Fogarty. She is a co-investigator on an NIH/Fogarty D43 to develop sustainable NeuroAIDS research capacity in Ibadan, Nigeria and has a longstanding collaboration with an infectious diseases team at Peking Union Medical College Hospital in Beijing, China. As the Department of Neurology’s global neurology flexible residency track leader, Dr. Chow is committed to mentoring junior investigators, particularly those from low and middle-income countries, in the intersecting spheres of neuro-infectious diseases, global health, and clinical research methods. She has championed greater diversity in research training, serving as a mentor in the NINDS-AAN TRANSCENDS R25 program, which trains promising early-career neurologists from underrepresented backgrounds in the conduct of high-quality neurologic research. She is also involved in the UCSF CHORI Summer Student Research Program, which pairs mentors with undergraduate students from disadvantaged backgrounds, racial/ethnic minorities, and other underrepresented groups. 

Dr. Chow cares for patients on the neurology service at San Francisco General Hospital and in the UCSF Neuro-Infectious Diseases Clinic. She consults on challenging neuro-infectious diseases cases locally, statewide, and nationally, including as part of the California CNS TB Expert Network. She served as vice-chair of the American Academy of Neurology Neuro-Infectious Diseases Section from 2017 to 2019 and co-chair of the American Neurological Association Global Neurology Specialty Interest Group. 

Learn more about Dr. Chow here.